Rigel Pharmaceuticals, Inc.
RIGL
$41.50
-$0.49-1.17%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 120.72% | 55.60% | 35.81% | -1.98% | -23.70% |
Total Receivables | 38.07% | 51.01% | 36.22% | 29.85% | 38.83% |
Inventory | 54.27% | 125.15% | 77.51% | 33.90% | -10.65% |
Prepaid Expenses | -9.55% | -36.75% | 1.66% | 118.71% | 51.35% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 85.16% | 58.47% | 36.10% | 12.04% | -6.15% |
|
|||||
Total Current Assets | 85.16% | 58.47% | 36.10% | 12.04% | -6.15% |
Net Property, Plant & Equipment | 82.96% | 62.09% | -67.06% | -57.93% | -44.31% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -8.31% | -8.15% | 95.27% | 95.72% | 96.18% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -11.64% | -64.89% | -53.03% | -3.93% | 775.23% |
Total Assets | 61.00% | 39.09% | 39.88% | 20.89% | 9.67% |
|
|||||
Total Accounts Payable | 18.92% | -57.37% | -53.25% | -52.31% | 16.98% |
Total Accrued Expenses | 45.03% | 55.39% | 58.24% | 47.19% | 12.52% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3,480.28% | -7.40% | -34.64% | -91.53% | -83.96% |
Total Finance Division Other Current Liabilities | -45.56% | -71.71% | 14.98% | 24.56% | 191.46% |
Total Other Current Liabilities | -45.56% | -71.71% | 14.98% | 24.56% | 191.46% |
Total Current Liabilities | 47.72% | -8.97% | 18.83% | 12.51% | 33.22% |
|
|||||
Total Current Liabilities | 47.72% | -8.97% | 18.83% | 12.51% | 33.22% |
Long-Term Debt | -62.43% | 0.02% | 0.08% | 1.35% | -0.88% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | 764.00% | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -21.17% | -0.50% | 10.16% | 4.69% | 9.03% |
|
|||||
Common Stock & APIC | 1.01% | 0.94% | 1.05% | 0.97% | 0.90% |
Retained Earnings | 6.90% | 2.63% | 1.24% | 0.28% | -1.01% |
Treasury Stock & Other | 166.67% | 60.00% | 25.00% | 173.33% | 64.00% |
Total Common Equity | 373.90% | 158.62% | 111.48% | 54.02% | -6.40% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 373.90% | 158.62% | 111.48% | 54.02% | -6.40% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 373.90% | 158.62% | 111.48% | 54.02% | -6.40% |
|